Literature DB >> 7964806

Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids.

D Chinchilla1, O Dulac, O Robain, P Plouin, G Ponsot, J F Pinel, D Graber.   

Abstract

Eight patients with Rasmussen's syndrome and epilepsia partialis continua were treated with high doses of steroids, including pulses of methylprednisolone and prednisone in decreasing doses. Three patients exhibited clinical, radiological, or histological evidence of bilateral involvement. Epilepsy and focal deficit decreased within six months in seven patients. Only five patients, in whom steroid treatment had begun less than 15 months after the onset of epilepsia partialis continua, experienced a lasting effect although they had periodic episodes of transient relapse. Treatment with high doses of steroids seems advisable during the first year after onset of epilepsia partialis continua, before hemiplegia has developed and in cases with bilateral involvement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964806      PMCID: PMC1073181          DOI: 10.1136/jnnp.57.11.1325

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Focal seizures due to chronic localized encephalitis.

Authors:  T RASMUSSEN; J OLSZEWSKI; D LLOYDSMITH
Journal:  Neurology       Date:  1958-06       Impact factor: 9.910

2.  Sudden death after treatment with pulsed methylprednisolone.

Authors:  P V Gardiner; I D Griffiths
Journal:  BMJ       Date:  1990-01-13

3.  Status epilepticus occurring during cortisone therapy.

Authors:  E H M STEPHEN; K B NOAD
Journal:  Med J Aust       Date:  1951-09-08       Impact factor: 7.738

4.  Progressive epilepsy due to chronic persistent encephalitis. Report of four cases.

Authors:  P C Gupta; S Roy; P N Tandon
Journal:  J Neurol Sci       Date:  1974-05       Impact factor: 3.181

5.  Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Authors:  P R Lyons; P K Newman; M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

6.  Progressive unilateral encephalopathy of childhood (Rasmussen's syndrome): a reappraisal.

Authors:  E P Vining; J M Freeman; J Brandt; B S Carson; S Uematsu
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

7.  Chronic focal encephalitis (Rasmussen syndrome): six cases.

Authors:  J H Piatt; P A Hwang; D C Armstrong; L E Becker; H J Hoffman
Journal:  Epilepsia       Date:  1988 May-Jun       Impact factor: 5.864

8.  High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.

Authors:  L Durelli; D Cocito; A Riccio; C Barile; B Bergamasco; G F Baggio; F Perla; M Delsedime; G Gusmaroli; L Bergamini
Journal:  Neurology       Date:  1986-02       Impact factor: 9.910

9.  ACTH and prednisone in childhood seizure disorders.

Authors:  O C Snead; J W Benton; G J Myers
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

10.  [Cytomegalovirus chorioretinitis: unusual and severe complications in renal transplantation. Importance of early diagnosis and prolonged treatment with DHPG].

Authors:  G Chong; G Mourad; P Lévy; G Nedelec; C Giudicelli; C Mion
Journal:  Nephrologie       Date:  1990
View more
  12 in total

Review 1.  [Recent insights into Rasmussen encephalitis].

Authors:  C G Bien; C E Elger
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

2.  What is the fate of disconnected brain tissue in a child with Rasmussen syndrome? A case report.

Authors:  Sun Jun Kim; Yong D Park; Jay Pillai
Journal:  Neuroradiology       Date:  2003-02-21       Impact factor: 2.804

3.  Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis?

Authors:  L Chiapparini; T Granata; L Farina; E Ciceri; A Erbetta; F Ragona; E Freri; L Fusco; G Gobbi; G Capovilla; L Tassi; L Giordano; M Viri; B Dalla Bernardina; R Spreafico; M Savoiardo
Journal:  Neuroradiology       Date:  2003-02-12       Impact factor: 2.804

Review 4.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

5.  Automated MRI Volumetric Analysis in Patients with Rasmussen Syndrome.

Authors:  Z I Wang; B Krishnan; D W Shattuck; R M Leahy; A N V Moosa; E Wyllie; R C Burgess; N B Al-Sharif; A A Joshi; A V Alexopoulos; J C Mosher; U Udayasankar; S E Jones
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-08       Impact factor: 3.825

6.  Increased activation of Iba1+ microglia in pediatric epilepsy patients with Rasmussen's encephalitis compared with cortical dysplasia and tuberous sclerosis complex.

Authors:  Martin Wirenfeldt; Ryan Clare; Spencer Tung; Alexander Bottini; Gary W Mathern; Harry V Vinters
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

7.  Late-onset Rasmussen encephalitis in Parry-Romberg syndrome: a case report.

Authors:  Giacomo Evangelista; Fedele Dono; Claudia Carrarini; Mirella Russo; Laura Bonanni
Journal:  Neurol Sci       Date:  2021-07-01       Impact factor: 3.307

8.  Rasmussen's Encephalitis.

Authors:  Dianne Counce; Nita Limdi; Ruben Kuzniecky
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.972

9.  Rasmussen's encephalitis presenting as focal cortical dysplasia.

Authors:  D J O'Rourke; A Bergin; A Rotenberg; J Peters; M Gorman; A Poduri; J Cryan; H Lidov; J Madsen; C Harini
Journal:  Epilepsy Behav Case Rep       Date:  2014-03-12

10.  A Case Series of Adult-Onset Rasmussen's Encephalitis: Diagnostic and Therapeutic Challenges.

Authors:  James Francis Castellano; Jenny A Meyer; Fred Alexander Lado
Journal:  Front Neurol       Date:  2017-10-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.